Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2440
https://www.valueinhealthjournal.com/article/S1098-3015(15)04516-7/fulltext
Title :
Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04516-7&doi=10.1016/j.jval.2015.09.2440
First page :
A668
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1850